期刊文献+

小鼠腹腔巨噬细胞对载环孢菌素A胶体亚微粒的摄取 被引量:4

The uptake of cyclosporine A loaded colloidal particles by mouse peritneal macrophage in vitro
下载PDF
导出
摘要 目的:研究巨噬细胞对载环孢菌素A胶体亚微粒的摄取,探讨环孢菌素A的作用机理及筛选适宜的制剂。方法:用3H环孢菌素A制备了纳米球、纳米囊、微乳三种胶体亚微粒,以小鼠腹腔巨噬细胞为细胞模型,将各胶体亚微粒与巨噬细胞在37℃条件下培养30min,分离胶体亚微粒与巨噬细胞,用液闪的方法测定细胞中cpm值作为摄取值。结果:纳米球可使小鼠腹腔巨噬细胞的cpm值达环孢菌素A溶液对照组的20倍,而纳米囊和微乳则使小鼠腹腔巨噬细胞的cpm值相对于环孢菌素A溶液对照组有明显降低。表面活性剂包裹及蛋白吸附对小鼠腹腔巨噬细胞的cpm值均有明显影响。结论:将环孢菌素A包埋于胶体亚微闰中可以改变其对巨噬细胞的靶向性。 OBJECTIVE:To investigate the uptake of cyclosporine A loaded colloidal particles by mouse peritoneal macrophage in vitro .METHODS: 3H labelled cyclosporine A (CyA) loaded colloidal particles:polylactic acid nanospheres,polylactic acid nanocapsulse and microemulsions were prepared.The 3H labelled cyclosporine A loaded colloidal praticles were incubated with mouse peritoneal macrophage (MPM) for 30 min at 37℃,then the cells were seperated from the colloidal particlae and the radioactivity (cpm) of 3H in the cells were measured by a liquid scintillation counter.RESULTS:Comparing with the solution of CyA,about 20 times increase of cpm value in MPM were observed when binding CyA with polylactic acid nanospheres while some obvious decrease was observed by binding CyA with polylactic acid nanocapsules or microemulsions.The surfactant coating and plasma protein adsorption were found to have some effect on the uptake of microemulsions or nanoparticles by MPM respectively.CONCLUSION:Colloidal drug carriers may affect the targeting of CyA to mononuclear phagocyte system.
出处 《中国药学杂志》 CAS CSCD 北大核心 2000年第2期88-90,共3页 Chinese Pharmaceutical Journal
关键词 环孢菌素A 纳米粒 小鼠 腹腔 巨噬细胞 cyclosporine A,nanoparticles,microemulsions,mouse peritoneal macrophage,uptake, in vitro
  • 相关文献

参考文献1

  • 1张强,药学学报,1996年,31卷,375页

同被引文献45

  • 1高明海.纳米级粒径超微粒化通用装置[J].中国科教创新导刊,1997(1):47-43. 被引量:20
  • 2Russell-Jones GJ, Veitch H, Arthur L. Lectin-mediated transport of nanoparticles across Caco-2 and OK cells[J], Int J Pharm, 1999, 190(2) : 165.
  • 3Tobio M,Sanchez A, Vila A, et al. The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanopartieles following oral administration [ J ]. Colloids Surg B Bioimerfaces, 2000, 18(3-4) :315.
  • 4Schroeder U, Schroeder H, Sabel BA. Body distribution of 3H-labelled dalargin bound to poly ( butylcyanoacrylate ) nano-particles after iv injections to mice[J]. Life Sci, 1999,66(6) :495.
  • 5Tokumitsu H, Hiratsuka J, Sakurai Y, et al, Gadolinium neutroncapture therapy using novel gadopenteticacid-chitosan complex nanoparticles: in vivo growth suppression of experimental melanoma solid tumor[J]. Cancer Lett,2000,150(2) : 177.
  • 6马铭安.中医治法与免疫学的关系[J].贵阳中医学院学报,1987,(2):29-29.
  • 7齐继成.纳米技术为医药产业“点石成金”[J].科技视野,2001,10(7):30-30.
  • 8钟光明.抗体促进病毒在巨噬细胞内的生长[J].国外医学:微生物学分册,1986,(5):207-209.
  • 9钟光明.单核吞噬细胞系统细胞毒素[J].国外医学:免疫学分册,1986,(3):147-149.
  • 10陈德昌 席修明.感染细胞因子与多器官功能衰竭[J].中华医学杂志,1991,71(12):717-719.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部